927 related articles for article (PubMed ID: 27110317)
21. Neurostimulation therapies in major depressive disorder: A decision-analytic model.
Teng M; Khoo AL; Zhao YJ; Abdin E; Mok YM; Lim BP; Tor PC
Early Interv Psychiatry; 2021 Dec; 15(6):1531-1541. PubMed ID: 33254283
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness analysis comparing repetitive transcranial magnetic stimulation therapy with antidepressant treatment in patients with treatment-resistant depression in Japan.
Noda Y; Miyashita C; Komatsu Y; Kito S; Mimura M
Psychiatry Res; 2023 Dec; 330():115573. PubMed ID: 37939593
[TBL] [Abstract][Full Text] [Related]
23. The role of transcranial magnetic stimulation in treatment-resistant depression: a review.
Lee JC; Blumberger DM; Fitzgerald PB; Daskalakis ZJ; Levinson AJ
Curr Pharm Des; 2012; 18(36):5846-52. PubMed ID: 22681165
[TBL] [Abstract][Full Text] [Related]
24. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: a systematic review and meta-analysis.
Ren J; Li H; Palaniyappan L; Liu H; Wang J; Li C; Rossini PM
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():181-9. PubMed ID: 24556538
[TBL] [Abstract][Full Text] [Related]
25. The priming effect of repetitive transcranial magnetic stimulation on clinical response to electroconvulsive therapy in treatment-resistant depression: a randomized, double-blind, sham-controlled study.
Rothärmel M; Quesada P; Husson T; Harika-Germaneau G; Nathou C; Guehl J; Dalmont M; Opolczynski G; Miréa-Grivel I; Millet B; Gérardin E; Compère V; Dollfus S; Jaafari N; Bénichou J; Thill C; Guillin O; Moulier V
Psychol Med; 2023 Apr; 53(5):2060-2071. PubMed ID: 34579796
[TBL] [Abstract][Full Text] [Related]
26. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: a meta-analysis of stimulus parameter effects.
Xie J; Chen J; Wei Q
Neurol Res; 2013 Dec; 35(10):1084-91. PubMed ID: 23889926
[TBL] [Abstract][Full Text] [Related]
27. Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies.
Greenhalgh J; Knight C; Hind D; Beverley C; Walters S
Health Technol Assess; 2005 Mar; 9(9):1-156, iii-iv. PubMed ID: 15774232
[TBL] [Abstract][Full Text] [Related]
28. Low-frequency repetitive transcranial magnetic stimulation inferior to electroconvulsive therapy in treating depression.
Hansen PE; Ravnkilde B; Videbech P; Clemmensen K; Sturlason R; Reiner M; Parner E; Rosenberg R; Vestergaard P
J ECT; 2011 Mar; 27(1):26-32. PubMed ID: 20351570
[TBL] [Abstract][Full Text] [Related]
29. Effect of electroconvulsive therapy on cortical excitability in patients with major depression: a transcranial magnetic stimulation study.
Chistyakov AV; Kaplan B; Rubichek O; Kreinin I; Koren D; Hafner H; Feinsod M; Klein E
Clin Neurophysiol; 2005 Feb; 116(2):386-92. PubMed ID: 15661116
[TBL] [Abstract][Full Text] [Related]
30. A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression.
Blumberger DM; Mulsant BH; Fitzgerald PB; Rajji TK; Ravindran AV; Young LT; Levinson AJ; Daskalakis ZJ
World J Biol Psychiatry; 2012 Sep; 13(6):423-35. PubMed ID: 21736507
[TBL] [Abstract][Full Text] [Related]
31. Comparative efficacy and acceptability of electroconvulsive therapy versus repetitive transcranial magnetic stimulation for major depression: A systematic review and multiple-treatments meta-analysis.
Chen JJ; Zhao LB; Liu YY; Fan SH; Xie P
Behav Brain Res; 2017 Mar; 320():30-36. PubMed ID: 27876667
[TBL] [Abstract][Full Text] [Related]
32. Prostatic Artery Embolization for Benign Prostatic Hyperplasia: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(6):1-139. PubMed ID: 34188733
[TBL] [Abstract][Full Text] [Related]
33. Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression.
Degerlund Maldi K; Asellus P; Myléus A; Norström F
BMC Psychiatry; 2021 Dec; 21(1):610. PubMed ID: 34876085
[TBL] [Abstract][Full Text] [Related]
34. Remission rate of transcranial magnetic stimulation compared with electroconvulsive therapy: a case-control study.
Svensson AF; Khaldi M; Engström I; Matusevich K; Nordenskjöld A
Nord J Psychiatry; 2018 Oct; 72(7):471-476. PubMed ID: 30359165
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of preoperative motor mapping with navigated transcranial magnetic brain stimulation in patients with high-grade glioma.
Butenschön VM; Ille S; Sollmann N; Meyer B; Krieg SM
Neurosurg Focus; 2018 Jun; 44(6):E18. PubMed ID: 29852777
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of alternative treatments for depression in low-income women.
Beil H; Beeber LS; Schwartz TA; Lewis G
J Ment Health Policy Econ; 2013 Jun; 16(2):55-65. PubMed ID: 23999203
[TBL] [Abstract][Full Text] [Related]
37. Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis.
Mutz J; Vipulananthan V; Carter B; Hurlemann R; Fu CHY; Young AH
BMJ; 2019 Mar; 364():l1079. PubMed ID: 30917990
[TBL] [Abstract][Full Text] [Related]
38. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Adult and Youth Populations: A Systematic Literature Review and Meta-Analysis.
Leggett LE; Soril LJ; Coward S; Lorenzetti DL; MacKean G; Clement FM
Prim Care Companion CNS Disord; 2015; 17(6):. PubMed ID: 27057417
[TBL] [Abstract][Full Text] [Related]
39. Evaluating the evidence on comparative effectiveness and value of management options for treatment-resistant depression.
Emond SK; Ollendorf DA; Colby JA; Reed SJ; Pearson SD
Postgrad Med; 2013 Nov; 125(6):7-16. PubMed ID: 24200756
[TBL] [Abstract][Full Text] [Related]
40. Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer.
Lam SW; Wai M; Lau JE; McNamara M; Earl M; Udeh B
Pharmacotherapy; 2017 Jan; 37(1):94-103. PubMed ID: 27870079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
